Analysts agree that Kenvue's Neutrogena needs a face-lift
WEB17 hours ago · But Jefferies’ Devas thinks Kenvue (KVUE) is in the early stages of a transformation as a “business that was run for cash is now being primed for growth.”. With the expectation for an ...
Kenvue becomes a fully independent company following final …
WEBSKILLMAN, N.J. August 23, 2023 – Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced its separation from Johnson & Johnson, marking its first day as a fully independent company.
News details - Kenvue
WEBAug 23, 2023 · Kenvue Inc. (NYSE: KVUE) (“Kenvue”) today announced its separation from Johnson Johnson, marking its first day as a fully independent company.
Kenvue reports first quarter 2024 results - A new view of care
WEBMay 7, 2024 · Kenvue reports first quarter 2024 results - Q1’24: Net sales increased 1.1% to $3.9 billion with organic growth 1 of 1.9% - Q1’24: Diluted earnings per share of $0.15; adjusted diluted earnings per share 1 of $0.28 - Reaffirms fiscal year 2024 outlook
Kenvue Reports Second Quarter 2024 Results
WEBAug 6, 2024 · Net Sales of $4.0 Billion decreased 0.3%; Organic Growth 1 was +1.5%. Diluted EPS was $0.03; Adjusted Diluted EPS 1 was $0.32. Productivity gains fuel accelerated investment in brands for future growth. Reaffirms Outlook for FY24 Net Sales Growth and Adjusted Diluted EPS.
Johnson & Johnson Announces Kenvue as the Name for Planned …
WEBSep 28, 2022 · Johnson & Johnson Announces Kenvue as the Name for Planned New Consumer Health Company. Modern name, purpose, and visual identity mark inspiring next chapter for maker of iconic, trusted brands, including Tylenol, Neutrogena, Listerine, and Band-Aid Brand. September 28, 2022.
Johnson & Johnson Announces Kenvue as the Name for
WEBSep 28, 2022 · NEW BRUNSWICK, N.J.-- (BUSINESS WIRE)--Johnson & Johnson (the “Company”) (NYSE: JNJ) today took another step forward in establishing two independent, market-leading companies with the announcement...
Kenvue reports full year and fourth quarter 2023 results
WEBSKILLMAN, N.J. February 8, 2024 – Kenvue Inc. (NYSE: KVUE) (“Kenvue”), the world’s largest pure-play consumer health company by revenue, today announced financial results for the fiscal full year and fourth quarter ended December 31, 2023.
J&J spinoff Kenvue CEO looks to innovation after IPO
WEBMay 5, 2023 · Kenvue CEO Thibaut Mongon is betting on brand and product innovation to drive growth after its solid debut on the public market Thursday. Kenvue, J&J’s consumer health business spinoff, has an ...
J&J starts share exchange offer for consumer health spin-off Kenvue
WEBJuly 24 (Reuters) - Johnson & Johnson (JNJ.N) said on Monday it had launched an exchange offer under which its stockholders can opt for shares of Kenvue <KVUE.N>, its newly listed consumer health...